Pyridostigmine Bromide Tablet
Product Images NDC 64980-220

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 64980-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Pyridostigmine Logo)

FDA Label Image

Structure (Pyridostigmine Structre)

Chemical structure of Pyridostigmine Bromide showing its molecular arrangement, with a pyridinium ring, a methyl group, and a bromide ion.*

FDA Label Image

Label (Pyridostigmine30ct)

Pyridostigmine Bromide Extended-Release Tablets 180 mg oral tablets label from Rising Pharma Holdings, Inc. The carton front states 30 tablets with a caution note about moisture sensitivity and keeping the desiccant. Additional text describes the tablet strength, extended-release form, storage conditions, and dispensing instructions. Manufactured by Centaur Pharmaceuticals in India and distributed by Rising Pharmaceuticals, NJ, USA, with visible barcodes and revision date of 10/2018.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.